1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. ORGANOID TECHNOLOGY MARKET BY TYPE
4.1. Introduction
4.2. Cerebral Organoid
4.3. Thyroid Organoid
4.4. Thymic Organoid
4.5. Testicular Organoid
4.6. Hepatic Organoid
4.7. Others
5. ORGANOID TECHNOLOGY MARKET BY APPLICATION
5.1. Introduction
5.2. Cancer Research
5.3. Drug Testing
5.4. Others
6. ORGANOID TECHNOLOGY MARKET BY END-USER
6.1. Introduction
6.2. Biotechnology And Pharmaceutical Companies
6.3. Academic And Research Institutions
7. ORGANOID TECHNOLOGY MARKET BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. USA
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe Middle East and Africa
7.4.1. Germany
7.4.2. France
7.4.3. UK
7.4.4. Spain
7.4.5. Italy
7.4.6. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. South Korea
7.5.4. Taiwan
7.5.5. Thailand
7.5.6. India
7.5.7. Indonesia
7.5.8. Others
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.1. STEMCELL Technologies Inc.
9.2. Hubrecht Organoid Technology
9.3. DefiniGEN Limited
9.4. Cellesce Ltd.
9.5. Merck KGaA
9.6. Thermo Fisher Scientific Inc.
9.7. Corning Incorporated
9.8. InSphero AG
9.9. 3Dnamics Inc.
9.10. Organoid Therapeutics
9.11. R&D Systems, Inc.
9.12. Organovo Holdings, Inc.
9.13. Greiner Bio-One International GmbH
9.14. Biopredic International
9.15. Ncardia
9.16. Newcells Biotech Limited
9.17. Sino Biological Inc.
9.18. Eurofins Scientific SE
9.19. Molecular Devices, LLC
10. APPENDIX
10.1. Currency
10.2. Assumptions
10.3. Base and Forecast Years Timeline
10.4. Key benefits for the stakeholders
10.5. Research Methodology
10.6. Abbreviations